Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Steder

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|November 18, 2010
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 functionBrigitte M Pützer, Marc Steder, Vijay Alla
Cellular and Molecular Life Sciences : CMLS|December 17, 2009
Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell deathDavid Engelmann, Susanne Knoll, Daniel Ewerth, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|November 18, 2010
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 functionBrigitte M Pützer, Marc Steder, Vijay Alla
Cellular and Molecular Life Sciences : CMLS|December 17, 2009
Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell deathDavid Engelmann, Susanne Knoll, Daniel Ewerth, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Pageof 1